The Sin of Exclusion: Applicability of Trials Encouraging Omission of Radiation Therapy to Nonwhite Patients With Breast Cancer-Reference-Cited by-同舟云学术

The Sin of Exclusion: Applicability of Trials Encouraging Omission of Radiation Therapy to Nonwhite Patients With Breast Cancer

Published:2018-11 Issue:11 Volume:14 Page:635-638
ISSN:1554-7477
Container-title:Journal of Oncology Practice
language:en
Short-container-title:JOP

Author:

McClelland Shearwood¹,Xanthopoulos Eric P.¹,Mitin Timur¹

Affiliation:

1. Indiana University School of Medicine, Indianapolis, IN; University of Wisconsin School of Medicine, Madison, WI; and Oregon Health and Science University, Portland, OR

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Health Policy,Oncology(nursing),Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JOP.18.00344

Reference15 articles.

1. Lumpectomy Plus Tamoxifen With or Without Irradiation in Women Age 70 Years or Older With Early Breast Cancer: Long-Term Follow-Up of CALGB 9343

2. Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial

3. Lumpectomy Plus Tamoxifen or Anastrozole With or Without Whole Breast Irradiation in Women With Favorable Early Breast Cancer

4. Tamoxifen, Radiation Therapy, or Both for Prevention of Ipsilateral Breast Tumor Recurrence After Lumpectomy in Women With Invasive Breast Cancers of One Centimeter or Less

5. Tamoxifen with or without Breast Irradiation in Women 50 Years of Age or Older with Early Breast Cancer

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigator utilization among African-American Breast cancer patients at a Comprehensive Cancer Center;Reports of Practical Oncology and Radiotherapy;2023-10-05

2. From Evidence to Practice: Are Low-Risk Breast Cancer Patients still Enduring Unnecessary Costs of Radiation?;The American Surgeon;2019-12